Protein Polymer Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

Protein Polymer Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Protein Polymer Technologies Inc. and its competitors. This provides our Clients with a clear understanding of Protein Polymer Technologies Inc. position in the Pharmaceuticals and Biotechnology Industry.

Scope

• The report contains the company’s profile and data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• The SWOT-analysis provides information about the company’s strengths, weaknesses, opportunities, and possible threats against it.
• The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency.
• It also shows the company’s income statement and ratio trend-charts, with balance sheets and cash flows presented on an annual and quarterly basis.
• Company’s financial ratios are directly compared with those of its competitors through industry averages.
• The report provides relevant news, an analysis of PR-activity, and stock price movements.
• The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms.

The benefits of buying the Report are as follows:

• Readers will gain an unrivalled in-depth knowledge about the company.
• The report will help the management of your business environment. This will be achieved through the report’s unique analysis of both the market and company’s competitors, and by providing detailed information about the internal and external factors that affect the relevant industry.
• Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• The report will help you to find prospective partners and suppliers.
• The annual profitability data provided in the report will assist and strengthen your company’s decision-making processes.

About Protein Polymer Technologies Inc.

Protein Polymer Technologies, Inc., a biotechnology company, engages in the research, development, and production of bio-active devices to improve medical and surgical outcomes. Through its patented technology to produce proteins of unique design, biological, and physical product components are integrated to provide for optimized clinical performance.

The products that the company has targeted for development are based on a generation of biomaterials which have been designed to be recognized and accepted by human cells to aid in the natural process of bodily repair, (including the healing of tissue and the restoration or augmentation of its form and function) and to promote the regeneration of tissues.

The company, through its proprietary technology, produces high molecular weight polymers that could be processed into various material forms, such as gels, sponges, films, and fibers, with their physical strength and rate of resorption tailored to each potential product application. These polymers are constructed of the same amino acids as natural proteins found in the body.

Fundamental Protein Polymers

The company’s primary products under development are based on protein polymers combining selected properties from two of the structural proteins found in nature: silk and elastin. The company also has created protein polymers based on repeating blocks of amino acids found in two other classes of structural proteins found in nature: collagen and keratin. The company focuses internally on developing protein polymers that are useful in products for: tissue augmentation, tissue adhesives and sealants, and drug delivery devices.

The company’s internal product development efforts are targeted toward various markets based on a common biomaterials platform. These include: injectable disc nucleus for the treatment of injured or degenerated spinal discs, strong and fast-setting, resorbable surgical sealants for use in general and cardiovascular procedures following primary wound closure, adhesion barriers, and scaffolds for wound healing and tissue engineering. Other markets of interest include those for drug delivery devices.

Product Candidates and Markets

The company’s protein polymer technology and materials have the potential to create products useful in various medical markets.

Surgical Tissue Sealants (STS): The company has developed surgical adhesives and sealants that are for the surgeon to use, and that combine the biocompatibility of fibrin glues (without the risks associated with use of blood-derived products) with the fast setting times of cyanoacrylates. A non-resorbable adhesive or sealant could only be used where the damaged tissues are not going to grow together. The company has demonstrated both the adhesive performance and the biocompatibility of its product formulations in preclinical studies, including resorption of the adhesive matrix in conjunction with the progression of wound healing.

Wound Healing & Tissue Regeneration: The market for wound care products is segmented, involving various different approaches to wound care. Products marketed and being developed by other parties includes fabric dressings (such as gauze), synthetic materials (such as polyurethane films), and biological materials (such as growth factors and living tissue skin graft substitutes).

The company has developed protein polymers that might be useful in the treatment of dermal wounds, particularly chronic wounds, such as decubitous ulcers, where both reconstruction of the extracellular matrix (ECM) and re-establishment of its function are desired. These polymers, based on key ECM protein sequence blocks, are biocompatible, fully resorbable and have been processed into gels, sponges, films, and fibrous sheets. Additionally, such materials might serve as scaffolds for the ex vivo production of living tissue substitutes.

Urethral Bulking Agent (UBA) - Polymer 47K: UBA relieves female stress incontinence by injecting liquid that rapidly changes to long-lasting solid bulk to the tissue surrounding the urethra. The company’s UBA injection procedure, an alternative to surgery, most often requires only one treatment. The UBA gel is resistant to migration. A human clinical feasibility study has been completed.

Collaborative and License Agreements

Spine Wave, Inc.: The company is a technology partner with Spine Wave, Inc. (‘Spine Wave’). The company used its patented tissue adhesive technology to create Spine Wave’s NuCore intervertebral disc repair material. It manufactured the NuCore material for Spine Wave’s clinical trials. Spine Wave’s NuCore Injectable Nucleus device, based on its patented tissue adhesive technology, is an injectable protein polymer formulation for repair of spinal discs damaged as a result of injury or aging. Spine Wave has enrolled patients in Degenerative Disc Disease and microdiscectomy studies of the NuCore Injectable Nucleus device in four countries: Switzerland, Australia, Germany and the United States.

Genencor International, Inc.: The company, in December 2000, signed a broad-based, worldwide exclusive license agreement with Genencor International, Inc. (Genencor) enabling Genencor, potentially, to develop various new products for industrial markets. In October 2002, the license agreement was amended to provide Genencor with an additional one-year option to initiate development in the field of non-medical personal care products. In March 2005, the license was amended to incorporate the field of personal care products into the license. As a result of the agreements, Genencor might use its patented protein polymer design and production technology.

Competition

The company competes with DuPont and BioElastics Research, Ltd.

History

Protein Polymer Technologies, Inc. was founded in 1988.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. PROTEIN POLYMER TECHNOLOGIES INC. COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. PROTEIN POLYMER TECHNOLOGIES INC. BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. PROTEIN POLYMER TECHNOLOGIES INC. SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. PROTEIN POLYMER TECHNOLOGIES INC. FINANCIAL ANALYSIS

4.1. Financial Statements
  4.1.1. Income Statement
  4.1.2. Balance Sheet
  4.1.3. Cash Flow
4.2. Financial Ratios
  4.2.1. Profitability
  4.2.2. Margin Analysis
  4.2.3. Asset Turnover
  4.2.4. Credit Ratios
  4.2.5. Long-Term Solvency
  4.2.6. Growth Over Prior Year
  4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. PROTEIN POLYMER TECHNOLOGIES INC. COMPETITORS AND INDUSTRY ANALYSIS

5.1. Protein Polymer Technologies Inc. Direct Competitors
5.2. Comparison of Protein Polymer Technologies Inc. and Direct Competitors Financial Ratios
5.3. Comparison of Protein Polymer Technologies Inc. and Direct Competitors Stock Charts
5.4. Protein Polymer Technologies Inc. Industry Analysis
  5.4.1. Pharmaceuticals and Biotechnology Industry Snapshot
  5.4.2. Protein Polymer Technologies Inc. Industry Position Analysis

6. PROTEIN POLYMER TECHNOLOGIES INC. NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. PROTEIN POLYMER TECHNOLOGIES INC. EXPERTS REVIEW

7.1. Experts Opinion
7.2. Experts Estimates

APPENDIX 1: RATIO DEFINITIONS

LIST OF TABLES

Table 1. Protein Polymer Technologies Inc. Key Facts
Table 2. Protein Polymer Technologies Inc. Profitability
Table 3. Protein Polymer Technologies Inc. Management Effectiveness
Table 4. Protein Polymer Technologies Inc. Income Statement Key Figures
Table 5. Protein Polymer Technologies Inc. Balance Sheet Key Figures
Table 6. Protein Polymer Technologies Inc. Cash Flow Statement Key Figures
Table 7. Financial Performance Abbreviation Guide
Table 8. Protein Polymer Technologies Inc. Key Executives
Table 9. Protein Polymer Technologies Inc. Key Executives Biographies *
Table 10. Protein Polymer Technologies Inc. Key Executives Compensations *
Table 11. Protein Polymer Technologies Inc. Key Executives Stock Options *
Table 12. Protein Polymer Technologies Inc. Major Shareholders
Table 13. Protein Polymer Technologies Inc. History
Table 14. Protein Polymer Technologies Inc. Products
Table 15. Protein Polymer Technologies Inc. Revenues by Product
Table 16. Protein Polymer Technologies Inc. Revenues by Region
Table 17. Protein Polymer Technologies Inc. Offices and Representations
Table 18. Protein Polymer Technologies Inc. SWOT Analysis
Table 19. Protein Polymer Technologies Inc. Income Statement 2008-2011 Including 4-years Trends
Table 20. Protein Polymer Technologies Inc. Income Statement Latest 4 Quarters Including Trends
Table 21. Protein Polymer Technologies Inc. Balance Sheet 2008-2011 Including Trends
Table 22. Protein Polymer Technologies Inc. Balance Sheet Latest 4 Quarters Including Trends
Table 23. Protein Polymer Technologies Inc. Cash Flow 2008-2011 Including Trends
Table 24. Protein Polymer Technologies Inc. Cash Flow Latest 4 Quarters Including Trends
Table 25. Protein Polymer Technologies Inc. Profitability Ratios
Table 26. Protein Polymer Technologies Inc. Margin Analysis Ratios
Table 27. Protein Polymer Technologies Inc. Asset Turnover Ratios
Table 28. Protein Polymer Technologies Inc. Credit Ratios
Table 29. Protein Polymer Technologies Inc. Long-Term Solvency Ratios
Table 30. Protein Polymer Technologies Inc. Financial Ratios Growth Over Prior Year
Table 31. Protein Polymer Technologies Inc. Capital Market Snapshot
Table 32. Protein Polymer Technologies Inc. Direct Competitors Key Facts
Table 33. Protein Polymer Technologies Inc. Direct Competitors Profitability Ratios
Table 34. Protein Polymer Technologies Inc. Direct Competitors Margin Analysis Ratios
Table 35. Protein Polymer Technologies Inc. Direct Competitors Asset Turnover Ratios
Table 36. Protein Polymer Technologies Inc. Direct Competitors Credit Ratios
Table 37. Protein Polymer Technologies Inc. Direct Competitors Long-Term Solvency Ratios
Table 38. Pharmaceuticals and Biotechnology Industry Statistics
Table 39. Protein Polymer Technologies Inc. Industry Position
Table 40. Protein Polymer Technologies Inc. vs. Industry Income Statement Analysis
Table 41. Protein Polymer Technologies Inc. vs. Industry Balance Sheet Analysis
Table 42. Protein Polymer Technologies Inc. vs. Industry Cash Flow Analysis
Table 43. Protein Polymer Technologies Inc. vs. Industry Ratios Comparison
Table 44. Protein Polymer Technologies Inc. Consensus Recommendations*
Table 45. Protein Polymer Technologies Inc. Analyst Recommendation Summary*
Table 46. Protein Polymer Technologies Inc. Price Target Summary*
Table 47. Protein Polymer Technologies Inc. Experts Recommendation Trends*
Table 48. Protein Polymer Technologies Inc. Revenue Estimates Analysis*
Table 49. Protein Polymer Technologies Inc. Earnings Estimates Analysis*
Table 50. Protein Polymer Technologies Inc. Historical Surprises*
Table 51. Protein Polymer Technologies Inc. Revenue Estimates Trend*
Table 52. Protein Polymer Technologies Inc. Earnings Estimates Trend*
Table 53. Protein Polymer Technologies Inc. Revenue Revisions*
Table 54. Protein Polymer Technologies Inc. Earnings Revisions*

LIST OF FIGURES

Figure 1. Protein Polymer Technologies Inc. Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Figure 2. Protein Polymer Technologies Inc. Profit Margin Chart
Figure 3. Protein Polymer Technologies Inc. Operating Margin Chart
Figure 4. Protein Polymer Technologies Inc. Return on Equity (ROE) Chart
Figure 5. Protein Polymer Technologies Inc. Return on Assets (ROA) Chart
Figure 6. Protein Polymer Technologies Inc. Debt to Equity Chart
Figure 7. Protein Polymer Technologies Inc. Current Ratio Chart
Figure 8. Protein Polymer Technologies Inc. 1-year Stock Charts
Figure 9. Protein Polymer Technologies Inc. 5-year Stock Charts
Figure 10. Protein Polymer Technologies Inc. vs. Main Indexes 1-year Stock Chart
Figure 11. Protein Polymer Technologies Inc. vs. Direct Competitors 1-year Stock Charts
Figure 12. Protein Polymer Technologies Inc. Article Density Chart

* – Data availability depends on company’s security policy.
The complete financial data is available for public traded companies.

The above Company Fundamental Report is a half-ready report.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get up-to-date version for the same price.